The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
What is the best predictor of future type 2 diabetes
Abstract
OBJECTIVE: We sought to assess insulin secretion/insulin resistance index in predicting the risk for future type 2 diabetes RESEARCH DESIGN AND METHODS: A total of 1,551 nondiabetic subjects from the San Antonio Heart Study received an oral glucose tolerance test (OGTT) with measurement of plasma glucose and insulin concentrations at 0, 30, 60, and 120 min at baseline and after 7-8 years of follow-up. Insulin secretion/insulin resistance index was calculated as the product of Matsuda index and DeltaI(0-30)/DeltaG(0-30) or DeltaI(0-120)/DeltaG(0-120). The discriminatory power of various prediction models for development of type 2 diabetes was tested with the area under the receiver-operating characteristic (ROC) curve. RESULTS: Insulin secretion/insulin resistance index (0- to 30- and 0- to 120-min time periods) had the greatest areas under the ROC curve (0.85 and 0.86, respectively), which were significantly greater than the 2-h plasma glucose concentration during the OGTT or the San Antonio Diabetes Prediction Model (SADPM) (P < 0.001 and P < 0.0001, respectively). A model based on the combination of the SADPM and a modified version of the insulin secretion/insulin resistance index or 1-h plasma glucose concentration had equal power to predict the risk for future type 2 diabetes compared with the insulin secretion/insulin resistance index. CONCLUSIONS: The insulin secretion/insulin resistance index is useful as a predictor of future development of type 2 diabetes. A model based on the combination of the SADPM and either a modified version of the insulin secretion/insulin resistance index or 1-h plasma glucose concentration can equally predict future type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
From Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism (2019) · cites this paper as [34]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationGlobal Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Self-citationAcarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Self-citationLindström, J., & Tuomilehto, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.725 · Cited by 1,862
Writing committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Järvinen, H., Van Haeften, T., Renn, W., & Gerich, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.295 · Cited by 1,042
A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test
Mari, A., Pacini, G., Murphy, E., Ludvik, B., & Nolan, J. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.539 · Cited by 806
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffner, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.4.701 · Cited by 641
Stern, M. P., Williams, K., & Haffner, S. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00006 · Cited by 510
Self-citationPrevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474
Hanson, R. L., Pratley, R. E., Bogardus, C., Narayan, K. M. V., Roumain, J. M. L., Imperatore, G., Fagot-Campagna, A., Pettitt, D. J., Bennett, P. H., & Knowler, W. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010187 · Cited by 463
Identifying Individuals at High Risk for Diabetes
Schmidt, M. I., Duncan, B. B., Bang, H., Pankow, J. S., Ballantyne, C. M., Golden, S. H., Folsom, A. R., Chambless, L. E., & for the Atherosclerosis Risk in Communities Investigators (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2013 · Cited by 455
STERN, M. P., ROSENTHAL, M., HAFFNER, S. M., HAZUDA, H. P., & FRANCO, L. J. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113956 · Cited by 308
Self-citationBurke, J. P., Williams, K., Gaskill, S. P., Hazuda, H. P., Haffner, S. M., & Stern, M. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.13.1450 · Cited by 294
Self-citationGulli, G., Ferrannini, E., Stern, M., Haffner, S., & DeFronzo, R. A. (1992) · Diabetes · doi:10.2337/diab.41.12.1575 · Cited by 283
Self-citationTrends in acute myocardial infarction coronary heart disease death in the United States
Gillum, R. F. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90367-0 · Cited by 228
Prediction of Type 2 Diabetes Using Simple Measures of Insulin Resistance
Hanley, A. J. G., Williams, K., Gonzalez, C., D’Agostino, R. B., Wagenknecht, L. E., Stern, M. P., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.463 · Cited by 201
Self-citationGulli, G., Ferrannini, E., Stern, M. P., et al. (1992) · Diabetes · doi:10.2337/diabetes.41.12.1575 · Cited by 93
Self-citationLack of Awareness and Treatment of Hyperlipidemia in Type II Diabetes in a Community Survey
D, M. P. S. M. (1989) · JAMA · doi:10.1001/jama.1989.03430030048032 · Cited by 92
Impact of the Increasing Burden of Diabetes on Acute Myocardial Infarction in New York City
Fang, J., & Alderman, M. H. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1196 · Cited by 65
Significance of impaired glucose tolerance in an Asian Indian population: a follow-up study
Ramachandran, A., Snehalatha, C., Naik, R. A. S., Mohan, V., Ramachandran, S., & Viswanathan, M. (1986) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(86)80019-5 · Cited by 28
Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey
Stern, M. P. (1989) · JAMA · doi:10.1001/jama.262.3.360 · Cited by 21
Self-citation
Cited by
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
Ma, R. C. W., & Chan, J. C. N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12098 · Cited by 827
Musso, G., Cassader, M., Rosina, F., & Gambino, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2446-4 · Cited by 661
Lowe, W. L., Scholtens, D. M., Kuang, A., Linder, B., Lawrence, J. M., Lebenthal, Y., McCance, D., Hamilton, J., Nodzenski, M., Talbot, O., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1646 · Cited by 574
Metadata
- Authors
- Abdul-Ghani, M. A., Williams, K., DeFronzo, R. A., & Stern, M.
- Affiliations
- From the Divisions of Diabetes and Clinical Epidemiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
- The University of Texas at San Antonio Health Science Center (US)
- ORCID
- DeFronzo, Ralph A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 30
- Issue
- 6
- Pages
- 1544-1548
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2170700107
- Cited by
- 355
- References
- 26
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 14 · 2023: 13 · 2022: 13 · 2021: 13 · 2020: 25 · 2019: 19 · 2018: 24 · 2017: 32 · 2016: 22 · 2015: 11 · 2014: 26 · 2013: 23 · 2012: 26
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
- National Center for Research Resources (M01RR001346, RR-01346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes prediction, Matsuda index, insulin secretion, insulin resistance, oral glucose tolerance test, 1-hour plasma glucose, diabetes risk prediction models, non-diabetic adults
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Medical History Taking, Middle Aged, Predictive Value of Tests, Texas, Mexican Americans, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.